Literature DB >> 25890452

Screening of patients with idiopathic venous thromboembolism for paroxysmal nocturnal hemoglobinuria clones.

Alejandro Lazo-Langner1, Michael J Kovacs2, Ben Hedley3, Fatimah Al-Ani2, Michael Keeney3, Martha L Louzada4, Ian Chin-Yee2.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an uncommon disorder characterized by hemolysis, thrombosis and marrow failure. Whereas venous and arterial thrombosis is a very common symptom of the disease, the frequency of PNH clones in patients with unexplained venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has not been studied. We conducted a cross sectional study evaluating the presence of PNH clones in patients with prevalent venous thromboembolism using a high sensitivity flow cytometry assay for erythrocytes and neutrophils. Among the 388 patients enrolled in the study one patient had a detectable PNH clone of 0.02% in the neutrophil population (0.26%; 95% CI 0.05 to 1.45) and no detectable erythrocyte clone. We conclude that the presence of PNH clones in patients with idiopathic venous thrombosis is rare. Screening for PNH clones among VTE patients might be better reserved for patients with signs of hemolysis.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Paroxysmal nocturnal hemoglobinuria; Venous thromboembolism

Mesh:

Year:  2015        PMID: 25890452     DOI: 10.1016/j.thromres.2015.04.006

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

Review 1.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide.

Authors:  Morag Griffin; Talha Munir
Journal:  Ther Adv Hematol       Date:  2016-12-21

Review 3.  Laboratory studies for paroxysmal nocturnal hemoglobinuria, with emphasis on flow cytometry.

Authors:  Margarida Lima
Journal:  Pract Lab Med       Date:  2020-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.